BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Report language for Labor HHS and VA-Milcon Annual Appropriations Bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
| CRYSTAL RILEY New | — |
Taxation/Internal Revenue Code TAX
HR4213 -The tax Extenders Act of 2009; HR5297; The Small Business Jobs and Credit Act HR 4853: The tax relief, unemployment Insurance Reauthorization and job Creation Act of 2010, as they related to the R&D tax credit Device Tax Legislation. HR 3630, Middle Class Tax Relief and Job Creation Act (this is the payroll tax relief extension bill) S. 1813, MAP-21 Act (the Senate highway bill with pension relief) HR 4196 and S.2240, extension of bonus depreciation S.2240/HR 4196, to extend bonus depreciation; and S. 2237, the Small Business Jobs and Tax Relief Act, as it relates to bonus depreciation. S. 1813/HR 4348, MAP-21, as it relates to pension funding relief. Issues related to the R&D tax credit, the taxation of U.S. multinational corporations and corporate tax reform. S. 3521, The Family and Business Tax Cut Certainty Act of 2012, HR 8, the American Taxpayer Relief Act. H.Con.Res. 25 S.Con. Res. Budget Resolutions S.886, S. 1013, H.R.845, H.R. 2024 Intellectual Property
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA GABRIELLE BUCCILLI New | — |
| JACK MANIKO | — |
| JOSEPH V SCHWAN | — |
Copyright/Patent/Trademark CPT
H R 3309 Improving the Patent System to promote American Competitiveness and Innovation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA GABRIELLE BUCCILLI New | — |
| JED PERRY | — |
| JOSEPH V SCHWAN | — |
Trade (domestic/foreign) TRD
H.R. 1295 Trade Preferences Extension Act of 2015. Support opening international markets by supporting the Trade Promotion Authority and the Trans Pacific Partnership agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA GABRIELLE BUCCILLI New | — |
Health Issues HCR
340B Drug Discount Program; FDA Regulatory Environment. Raise awareness with legislators about the benefits of home dialysis. Disease registry for Mutifocal Motor Neuropathy at NIH. Orphan Drug Act; Biosimilars Raise Awareness with legislators about survey and certification issues as it relates to home dialysis. Telehealth Modernization Act of 2015- Calls for states to authorize health care professionals to deliver health care to individuals through telehealth and consider adopting various conditions under which a health care professional delivering care through telehealth should perform such services
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
| CRYSTAL RILEY New | — |
| JOSEPH V SCHWAN | — |
Medicare/Medicaid MMM
Legislation to cut Medicare Part B Drug Reimbursement, Medicare Part B DME Competitive Bidding Program. Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. Pull through on Medicare demonstration to provide nursing services and supplies associated with home infusion of IVIG for patients with PIDD. HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure. Medicare Part B Drug Reimbursement. H.R. 8 American Taxpayer Relief Act of 2012 -- working to mitigate the impact to kidney patients of the payment reductions required by the Act. HR 3306: Telehealth Enhancement Act of 2013. The Chronic Kidney Disease Improvement in Research and Treatment Act is S.598 and H.R.1130
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
| CRYSTAL RILEY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.